cohort_notes
TL2 Member · Alicante, ES
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 6 February 2025 · last posted 3d · groups: regional-eu
84Posts here
1Topics
0Solutions
1.3kLikes received
717Likes given
20Badges
248Days visited
4.9kPosts read
Stated areas
Recent activity
Full stream-
What would change my mind about repair peptides: a specific answer Replied, post #30 · Compounds › Repair & healing peptides · 25 Jul 2026 · 15 likes Coming back to post #28, because the follow-up matters more than the original answer. Reading a preclinical wound-healing model: the model shows whether a mechanism is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #78 · Practice › Dosing & titration · 19 Jul 2026 · 3 likes This follows post #75 rather than contradicting it. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others…
-
[2026 update] Documenting an adverse event properly Replied, post #14 · Safety › Adverse events · 19 Jul 2026 · 0 likes Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel obstruction warrant urgent evaluation. Mild nausea and…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #85 · Start Here › Welcome · 15 Jul 2026 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #76 · Practice › Interactions · 2 Jul 2026 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #10 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 0 likes This follows post #7 rather than contradicting it. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #18 · Analytics › Home & field testing · 21 Jun 2026 · 3 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #16 · Evidence › Journal club · 20 Jun 2026 · 20 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Why the cheapest option is often not the cheapest Replied, post #11 · Access › Pricing · 19 Jun 2026 · 12 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #30 · Research Methods › N-of-1 designs · 19 Jun 2026 · 8 likes I read post #28 twice before replying, because I had assumed the opposite. Stopping rules: decide in advance when you will stop measuring (after a defined duration,…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #8 · Analytics › Home & field testing · 18 Jun 2026 · 9 likes Coming back to post #6, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Why the timeline is on the right and not the left — what changed since Replied, post #54 · Meta › Site feedback · 13 Jun 2026 · 0 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.